tlr recognition self nucleic acids hampers glucocorticoid activity lupus 
glucocorticoids widely used treat patients autoimmune diseases systemic lupus erythematosus sle12 however regimens used treat many conditions maintain disease control majority sle patients aggressive approaches high-dose methylprednisolone pulse therapy used provide transient reductions disease activity34 primary anti-inflammatory mechanism glucocorticoids thought nf-kappa b inhibition5 recognition self nucleic acids toll-like receptors tlr7 tlr9 b cells plasmacytoid dendritic cells pdcs important step pathogenesis sle6 promoting anti-nuclear antibodies production type interferon ifn correlated severity disease17 following activation self-nucleic acid-associated immune complexes pdcs migrate tissues89 demonstrate vitro vivo stimulation pdcs tlr7 can account reduced activity glucocorticoids inhibit ifn pathway sle patients two lupus-prone mouse strains triggering pdcs tlr7 nucleic acid-containing immune complexes synthetic ligands activates nf-kappa b pathway essential pdc survival glucocorticoids affect nf-kappa b activation pdcs preventing glucocorticoid induction pdc death consequent reduction systemic ifn-alpha levels findings unveil new role self nucleic acid recognition tlrs indicate inhibitors tlr7 signalling prove effective corticosteroid-sparing drugs 
